Healthcare - Biotechnology - NASDAQ - US
$ 1.97
-2.48 %
$ 156 M
Market Cap
-1.37
P/E
BALANCE SHEET
171 M
ASSETS
31.1 M
LIABILITIES
139 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Tenaya Therapeutics, Inc.
| Current Assets | 112 M |
| Cash & Short-Term Investments | 105 M |
| Receivables | 0 |
| Other Current Assets | 6.94 M |
| Non-Current Assets | 58.9 M |
| Long-Term Investments | 0 |
| PP&E | 53.3 M |
| Other Non-Current Assets | 5.68 M |
| Current Liabilities | 22.7 M |
| Accounts Payable | 5.63 M |
| Short-Term Debt | 8.64 M |
| Other Current Liabilities | 8.46 M |
| Non-Current Liabilities | 8.36 M |
| Long-Term Debt | 8.1 M |
| Other Non-Current Liabilities | 253 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 45.7 | 95.3 | 38.1 | 128.5 | 23.9 |
| Short Term Investments | 59.0 | 91.3 | 213.2 | 0 | 2.8 |
| Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | (19.9) | 0 | 0 | 0 |
| Other Current Assets | 6.9 | 11.3 | 8.1 | 1.4 | 1.1 |
| Total Current Assets | 111.6 | 193.8 | 255.4 | 130.0 | 27.7 |
| PP&E | 53.3 | 62.7 | 54.7 | 17.2 | 9.6 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 17.7 | 0.5 | 0.6 | 0.5 |
| Other Long Term Assets | 5.7 | 4.8 | 4.1 | 0.4 | 0.2 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 170.5 | 278.9 | 314.2 | 148.2 | 38.0 |
| LIABILITIES | |||||
| Accounts Payable | 5.6 | 9.6 | 10.7 | 1.0 | 0.6 |
| Short Term Debt | 8.6 | 8.0 | 4.0 | 0 | 0 |
| Other Current Liabilities | 8.5 | 6.7 | 7.1 | 4.0 | 3.5 |
| Total Current Liabilities | 22.7 | 24.2 | 21.8 | 5.0 | 4.1 |
| Long Term Debt | 8.1 | 11.1 | 13.7 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 2.5 | 0 | 0 |
| Other Liabilities | 0.3 | 0.2 | 0.2 | 224.4 | 77.6 |
| Total Liabilities | 31.1 | 278.9 | 35.7 | 229.5 | 81.7 |
| EQUITY | |||||
| Common Stock | 7 K | 7 K | 4 K | 1 K | 1 K |
| Retained Earnings | (403.3) | (279.2) | (155.5) | (82.8) | (44.4) |
| Other Accumulative Comprehensive Income/Loss | (0.1) | (0.4) | (0.1) | (0.2) | 74 K |
| Total Equity | 139.4 | 243.4 | 278.5 | (81.3) | (43.7) |
| Total Liabilities and Equity | 170.5 | 278.9 | 314.2 | 148.2 | 38.0 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 73.8 | 44.8 | 41.3 | 41.1 | 41.1 |